You are here

cell therapy

FDA shares additional draft guidance on cell and gene therapy

Clinical Trials Arena

Wed, 11/20/24 - 11:20 am

CSL Behring shuts down California cell and gene therapy R&D site amid group pivot

Fierce Biotech

Mon, 11/18/24 - 11:27 am

MD Anderson Cancer Center unveils cell therapy research institute that will work with biotech, pharma

Fierce Biotech

Mon, 11/11/24 - 06:29 pm

MD Anderson Cancer Center

Capricor cell therapy improves cardiac and upper limb function in phase 2 Duchenne muscular dystrophy victory lap

Fierce Biotech

Sun, 10/13/24 - 11:27 am

clinical trials

Duchenne Muscular Dystrophy

Astellas unveils new Japan site for cell therapy research arm Universal Cells, transferring 12 roles overseas

Fierce Biotech

Wed, 10/9/24 - 09:07 pm

Legend set to open Philadelphia cell therapy R&D site next year

Fierce Biotech

Thu, 10/3/24 - 10:12 am

Zephyrm rides IPO updraft toward Hong Kong listing, seeking cash for phase 3 cell therapy trials

Fierce Biotech

Wed, 10/2/24 - 10:40 am

Zephyrm Bioscience

graft vs host disease

After scoring a first for an off-the-shelf CAR-T, can Atara maintain momentum?

Pharma Voice

Mon, 09/30/24 - 09:17 am

Atara Biotherapeutics

2seventy Bio stops enrolling patients in blood cancer therapy study

Reuters

Wed, 09/25/24 - 11:56 am

Bristol Myers Squibb

Multiple Myeloma

clinical trials

Aurion launches eye disease cell therapy in its first market

Pharmaphorum

Wed, 09/25/24 - 11:42 am

bullous keratopathy

Startup from George Church’s lab raises $75M to develop ‘supercell’ medicines

BioPharma Dive

Thu, 09/19/24 - 09:20 pm

GC Therapeutics

Kyverna swaps CEOs, leaning on Kite veterans to lead ‘next chapter’

BioPharma Dive

Mon, 09/16/24 - 10:14 pm

Kyverna Therapeutics

Gilead Sciences

ArsenalBio raises $325M in one of the year’s largest biotech funding rounds

BioPharma Dive

Wed, 09/4/24 - 11:46 am

Bristol Myers Squibb

ProKidney halts one CKD cell therapy phase 3 trial considered surplus to FDA approval

Fierce Biotech

Tue, 09/3/24 - 11:19 am

chronic kidney disease

Cell and gene therapy investment, once booming, is now in a slump

BioPharma Dive

Thu, 08/29/24 - 11:22 am

This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment

Motley Fool

Thu, 08/29/24 - 11:10 am

autoimmune diseases

Q2 2024 update: cell & gene therapy related hiring actvity in the pharma industry

Clinical Trials Arena

Tue, 08/27/24 - 08:09 pm

Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development

PR Newswire

Tue, 08/6/24 - 11:19 am

Using AI to improve cell therapies in solid tumors, Outpace clinches $144M

First Word Pharma

Fri, 08/2/24 - 11:54 am

artificial intelligence

Galapagos pauses CAR-T cell therapy trial over Parkinsonism case

Fierce Biotech

Fri, 08/2/24 - 11:36 am

clinical trials

Pages